Loading...
524091 logo

Carysil LimitedBSE:524091 주식 보고서

시가총액 ₹33.5b
주가
n/a
1Y35.4%
7D-2.1%
1D-1.9%
포트폴리오 가치
보기

Carysil Limited

BSE:524091 주식 리포트

시가총액: ₹33.5b

Carysil (524091) 주식 개요

Carysil Limited는 자회사와 함께 인도에서 석영 주방 및 스테인리스 스틸 주방 싱크대, 욕실 제품, 타일, 주방 가전 및 액세서리를 제조 및 거래하고 있습니다. 자세히 보기

524091 펀더멘털 분석
스노우플레이크 점수
가치 평가1/6
미래 성장3/6
과거 실적5/6
재무 건전성6/6
배당3/6

강점

위험 분석

우리의 위험 점검에서 524091에 대한 위험이 감지되지 않았습니다.

524091 Community Fair Values

Create Narrative

See what 14 others think this stock is worth. Follow their fair value or set your own to get alerts.

Carysil Limited 경쟁사

가격 이력 및 성과

Carysil 주가의 최고가, 최저가 및 변동 요약
과거 주가
현재 주가₹1,177.80
52주 최고가₹1,249.95
52주 최저가₹734.00
베타0.56
1개월 변동9.22%
3개월 변동56.26%
1년 변동35.44%
3년 변동67.18%
5년 변동88.03%
IPO 이후 변동127,000.81%

최근 뉴스 및 업데이트

내러티브 업데이트 Jun 18

524091: Subsidiary Simplification And Dividend Plans Will Shape Future Share Performance

Analysts have kept their fair value estimate for Carysil steady at ₹1,270.50, with the small adjustments in discount rate, revenue growth, profit margin and future P/E assumptions leading to only a marginal refinement in the overall price target narrative. What’s in the News for Carysil Board meeting on May 20, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider a final dividend on equity shares for the financial year ended March 31, 2026.
내러티브 업데이트 Jun 02

524091: Subsidiary Simplification And Dividend Policy Will Support Future Upside

Carysil’s analyst price target is unchanged at ₹1,270.5, as analysts balance slightly adjusted assumptions for discount rate, revenue growth, profit margins and future P/E to arrive at the same fair value estimate. What's in the News A board meeting is scheduled for May 20, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider a final dividend on the equity shares for FY 2025-26.
내러티브 업데이트 May 17

524091: Subsidiary Rationalisation And QIP Extension Will Support Future Upside

Carysil’s analyst price target has changed from ₹1,205.67 to ₹1,270.50 as analysts incorporate slightly adjusted assumptions for the discount rate, revenue growth, profit margin and future P/E, resulting in a modestly higher fair value estimate. What's in the News A board meeting is scheduled on May 20, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider and recommend a final dividend, if any, on equity shares for the financial year ended March 31, 2026 (Key Developments).

Recent updates

내러티브 업데이트 Jun 18

524091: Subsidiary Simplification And Dividend Plans Will Shape Future Share Performance

Analysts have kept their fair value estimate for Carysil steady at ₹1,270.50, with the small adjustments in discount rate, revenue growth, profit margin and future P/E assumptions leading to only a marginal refinement in the overall price target narrative. What’s in the News for Carysil Board meeting on May 20, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider a final dividend on equity shares for the financial year ended March 31, 2026.
내러티브 업데이트 Jun 02

524091: Subsidiary Simplification And Dividend Policy Will Support Future Upside

Carysil’s analyst price target is unchanged at ₹1,270.5, as analysts balance slightly adjusted assumptions for discount rate, revenue growth, profit margins and future P/E to arrive at the same fair value estimate. What's in the News A board meeting is scheduled for May 20, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider a final dividend on the equity shares for FY 2025-26.
내러티브 업데이트 May 17

524091: Subsidiary Rationalisation And QIP Extension Will Support Future Upside

Carysil’s analyst price target has changed from ₹1,205.67 to ₹1,270.50 as analysts incorporate slightly adjusted assumptions for the discount rate, revenue growth, profit margin and future P/E, resulting in a modestly higher fair value estimate. What's in the News A board meeting is scheduled on May 20, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider and recommend a final dividend, if any, on equity shares for the financial year ended March 31, 2026 (Key Developments).
내러티브 업데이트 Apr 28

524091: Subsidiary Rationalisation And QIP Timeline Extension Will Support Future Upside

Analysts have kept Carysil’s fair value estimate broadly unchanged at about ₹1,205.67, with only small tweaks to the discount rate, revenue growth, profit margin and future P/E assumptions, leading to a steady overall price target narrative. What's in the News Board meeting scheduled on Mar 20, 2026 at 15:00 IST to review the appointment of an internal auditor and a cost auditor.
내러티브 업데이트 Apr 12

524091: Subsidiary Closures And QIP Utilisation Decisions Will Support Future Upside

Analysts have kept their average price target for Carysil broadly steady at around ₹1,205.67, citing largely unchanged assumptions on revenue growth, profit margins and future P/E, with only minor adjustments to the discount rate in their models. What's in the News A board meeting is scheduled on Feb 04, 2026 to consider and approve unaudited standalone and consolidated financial results for the quarter and nine months ended Dec 31, 2025 (Key Developments).
내러티브 업데이트 Mar 28

524091: Upcoming Board Decisions On Subsidiary Closures Will Support Future Upside

Analysts have kept their fair value estimate for Carysil steady at ₹1,205.67 per share, with only minimal tweaks to inputs such as the discount rate, revenue growth outlook, profit margin assumptions and future P/E. This reflects a view that recent data does not materially change the stock’s underlying valuation story.
내러티브 업데이트 Mar 11

524091: Upcoming Board Results And Stable Assumptions Will Support Future Upside

Analysts have maintained their fair value estimate for Carysil at ₹1,205.67 per share, while making refinements to inputs such as a slightly lower discount rate and minor adjustments to revenue growth, profit margin, and future P/E expectations to reflect updated assumptions in their models. What's in the News Carysil has scheduled a board meeting for February 4, 2026 to review and approve unaudited standalone financial results for the quarter and nine months ended December 31, 2025 (Key Developments).
내러티브 업데이트 Feb 25

524091: Upcoming Results And Steady Assumptions Will Support Future Upside

Analysts have maintained their fair value estimate for Carysil at ₹1,205.67 per share, making only minor model adjustments, such as a slightly higher discount rate and a modestly higher assumed future P/E multiple. These changes together leave the overall price target unchanged.
내러티브 업데이트 Feb 11

524091: Upcoming Results And Improved Margin Outlook Will Support Future Upside

Analysts have nudged their fair value estimate on Carysil higher from ₹1,165 to about ₹1,206, citing updated assumptions on discount rate, revenue growth, profit margins and future P/E that better reflect their current expectations for the business. What's in the News Carysil has scheduled a board meeting on February 4, 2026, to consider and approve its unaudited standalone financial results for the quarter and nine months ended December 31, 2025 (Key Developments).
내러티브 업데이트 Jan 27

524091: Steady Outlook And Upcoming Results Date Will Support Future Upside

Analysts have kept their fair value estimate for Carysil steady at ₹1,165, with only marginal tweaks to inputs like the discount rate and assumed future P/E. This reflects fine tuning of their models rather than a change in their core view.
내러티브 업데이트 Jan 10

524091: Steady Assumptions And Upcoming Results Will Support Future Upside

Analysts have maintained their price target for Carysil at ₹1,165 per share. This unchanged view mainly reflects consistent assumptions regarding fair value, discount rate, revenue growth, profit margin and future P/E.
내러티브 업데이트 Dec 15

524091: Capacity Expansion Will Drive Future Earnings Momentum

Analysts have modestly raised their price target on Carysil to ₹1,165 per share (from ₹1,165), reflecting slightly higher discount rate and valuation assumptions while keeping long term growth and margin expectations broadly unchanged. What's in the News Carysil has scheduled a board meeting on November 10, 2025 to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (company filing).
내러티브 업데이트 Dec 01

524091: Capacity Expansion And Dividend Increase Will Drive Upward Momentum

Analysts have raised their price target for Carysil from ₹1,130.33 to ₹1,165.00, citing improved forecasts for revenue growth and profit margins that support a higher fair value estimate. What's in the News A board meeting is scheduled for November 10, 2025 to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (Board Meeting).
내러티브 업데이트 Nov 16

524091: New Capacity Expansion And Dividend Increase Set To Shape Outlook

Analysts have increased Carysil's fair value estimate from ₹1,039 to ₹1,130.33, citing modest changes in growth forecasts and profit margins, which support a slightly higher valuation target. What's in the News Carysil's board will meet on November 10, 2025, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (Board Meeting).
내러티브 업데이트 Aug 18

Global Kitchen Upgrades And Market Expansion Will Transform Industry

Carysil’s consensus price target has been raised to ₹1039, reflecting a notable improvement in future earnings valuation as indicated by the decline in its forward P/E and a marginal uplift in expected revenue growth. What's in the News Board meeting scheduled to consider investment in a subsidiary company.
User avatar
새로운 내러티브 Feb 18

Partnerships With IKEA And Karran USA Will Drive Global Expansion In Kitchen Solutions

Carysil's global expansion and strategic partnerships in the U.S. are expected to significantly drive revenue growth and increase market presence.

주주 수익률

524091IN BuildingIN 시장
7D-2.1%-1.9%-0.5%
1Y35.4%-6.5%-2.3%

수익률 대 산업: 524091은 지난 1년 동안 -6.5%의 수익을 기록한 Indian Building 산업보다 더 좋은 성과를 냈습니다.

수익률 대 시장: 524091은 지난 1년 동안 -2.3%를 기록한 Indian 시장보다 더 좋은 성과를 냈습니다.

주가 변동성

Is 524091's price volatile compared to industry and market?
524091 volatility
524091 Average Weekly Movement6.9%
Building Industry Average Movement7.4%
Market Average Movement6.8%
10% most volatile stocks in IN Market9.9%
10% least volatile stocks in IN Market4.4%

안정적인 주가: 524091는 지난 3개월 동안 Indian 시장에 비해 주가 변동성이 크지 않았습니다.

시간에 따른 변동성: 524091의 주간 변동성(7%)은 지난 1년 동안 안정적이었습니다.

회사 소개

설립직원 수CEO웹사이트
1987n/aChirag Parekhwww.carysil.com

Carysil Limited는 자회사와 함께 인도에서 석영 주방 및 스테인리스 스틸 주방 싱크대, 욕실 제품, 타일, 주방 가전 제품 및 액세서리를 제조 및 거래하고 있습니다. 수도꼭지 및 음식물 쓰레기 처리기, 주방 표면, 석영 디자이너 타일, 굴뚝, 쿡탑, 와인 냉각기, 식기세척기, 빌트인 오븐, 전자레인지, 호브, 쿡레인지, 얼음 및 커피 메이커 등의 빌트인 주방 가전제품과 물장, 부속품, 수도꼭지 등의 욕실 제품 등을 제공합니다. 이 회사는 텍카리실, 카리실, 스턴하겐 브랜드로 제품을 판매하고 있습니다.

Carysil Limited 기초 지표 요약

Carysil의 순이익과 매출은 시가총액과 어떻게 비교됩니까?
524091 기초 통계
시가총액₹33.50b
순이익 (TTM)₹981.90m
매출 (TTM)₹9.24b
34.1x
주가수익비율(P/E)
3.6x
주가매출비율(P/S)

524091는 고평가되어 있습니까?

공정 가치 및 평가 분석 보기

순이익 및 매출

최근 실적 보고서(TTM)의 주요 수익성 지표
524091 손익계산서 (TTM)
매출₹9.24b
매출원가₹4.28b
총이익₹4.96b
기타 비용₹3.97b
순이익₹981.90m

최근 보고된 실적

Mar 31, 2026

다음 실적 발표일

해당 없음

주당순이익(EPS)34.52
총이익률53.63%
순이익률10.63%
부채/자본 비율43.9%

524091의 장기 실적은 어땠습니까?

과거 실적 및 비교 보기

배당

0.3%
현재 배당 수익률
9%
배당 성향

기업 분석 및 재무 데이터 상태

데이터최종 업데이트 (UTC 시간)
기업 분석2026/06/28 11:00
종가2026/06/25 00:00
수익2026/03/31
연간 수익2026/03/31

데이터 소스

당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.

패키지데이터기간미국 소스 예시 *
기업 재무제표10년
  • 손익계산서
  • 현금흐름표
  • 대차대조표
분석가 컨센서스 추정치+3년
  • 재무 예측
  • 분석가 목표주가
시장 가격30년
  • 주가
  • 배당, 분할 및 기타 조치
지분 구조10년
  • 주요 주주
  • 내부자 거래
경영진10년
  • 리더십 팀
  • 이사회
주요 개발10년
  • 회사 공시

* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.

별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 스노우플레이크

이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드YouTube 튜토리얼도 제공하고 있습니다.

Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.

산업 및 섹터 지표

산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.

분석가 소스

Carysil Limited는 7명의 분석가가 다루고 있습니다. 이 중 3명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.

분석가기관
Rishab BothraAnand Rathi Shares and Stock Brokers Limited
null nullAnand Rathi Shares and Stock Brokers Limited
Vyom ChhedaBP Wealth Management Private Limited